Deutsche Bank Ag\ Takeda Pharmaceutical CO LTD Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$12.42 - $15.62 $8,122 - $10,215	-654 Reduced 27.72%	1,705 $26,000
Q2 2021 Aug 11, 2021	SELL	$16.55 - $18.64 $3,740 - $4,212	-226 Reduced 8.74%	2,359 $40,000
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $6,115 - $7,283	-366 Reduced 12.4%	2,585 $47,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $27,532 - $33,937	-1,789 Reduced 37.74%	2,951 $54,000
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $6,258 - $7,023	366 Added 8.37%	4,740 $85,000
Q2 2020 Aug 13, 2020	SELL	$14.59 - $19.5 $42,383 - $56,647	-2,905 Reduced 39.91%	4,374 $78,000
Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $3.52 Million - $5.49 Million	-270,530 Reduced 97.38%	7,279 $110,000
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $4.23 Million - $5.22 Million	250,556 Added 919.37%	277,809 $5.48 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $565,201 - $629,596	-34,997 Reduced 56.22%	27,253 $466,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $2.98 Million - $3.68 Million	-179,684 Reduced 74.27%	62,250 $1.1 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $4.04 Million - $5.21 Million	241,934 New	241,934 $4.92 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.